Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seasonal Human Influenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00442975
What this trial is testing

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status

Who this might be right for
Influenza
Public Health England 100
Large-scale testing (Phase 3)Study completedNCT02935192
What this trial is testing

Phase 3 Trial of Serbian Seasonal Influenza Vaccine

Who this might be right for
Influenza
Institute of Virology, Vaccines and Sera, Torlak 480
Early research (Phase 1)Study completedNCT01609998
What this trial is testing

Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 75
Early research (Phase 1)Study completedNCT00724997
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Who this might be right for
Seasonal Human Influenza
AVIR Green Hills Biotechnology AG 48
Early research (Phase 1)Study completedNCT03814720
What this trial is testing

Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults

Who this might be right for
Influenza Infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT04192500
What this trial is testing

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Who this might be right for
Influenza
Osivax 300
Post-approval studies (Phase 4)Active Not RecruitingNCT04101838
What this trial is testing

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

Who this might be right for
Influenza
University of Alabama at Birmingham 50
Testing effectiveness (Phase 2)Study completedNCT00903552
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)

Who this might be right for
Seasonal Influenza
Novavax 221
Large-scale testing (Phase 3)Study completedNCT05310084
What this trial is testing

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 1,134
Testing effectiveness (Phase 2)Study completedNCT01685372
What this trial is testing

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Who this might be right for
Solid Organ Transplant Recipient (Liver, Kidney, Heart)Rheumatologic DisorderHuman Immunodeficiency Virus (HIV)+2 more
University of Colorado, Denver 16
Not applicableStudy completedNCT01224301
What this trial is testing

School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities

Who this might be right for
ImmunizationsVaccinationInfluenza+1 more
Monroe County Department of Public Health 25,366
Large-scale testing (Phase 3)Study completedNCT05330975
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 3,317
Early research (Phase 1)Study completedNCT02330003
What this trial is testing

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

Who this might be right for
Healthy
Il-Yang Pharm. Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT05981846
What this trial is testing

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Who this might be right for
SARS CoV 2 InfectionInfluenza, Human
Hipra Scientific, S.L.U 279
Not applicableStudy completedNCT04326309
What this trial is testing

Audio Data Collection for Identification and Classification of Coughing

Who this might be right for
COVID-19Coronavirus InfectionsHay Fever+6 more
HealthMode Inc. 336
Large-scale testing (Phase 3)Study completedNCT00957996
What this trial is testing

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Who this might be right for
Seasonal InfluenzaCoughSore Throat+4 more
BioCryst Pharmaceuticals 234
Not applicableStudy completedNCT01431183
What this trial is testing

Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions

Who this might be right for
Seasonal Influenza Vaccination
University of Michigan 3,618
Testing effectiveness (Phase 2)Study completedNCT01625689
What this trial is testing

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Who this might be right for
Influenza
PATH Vaccine Solutions 309
Not applicableStudy completedNCT06800885
What this trial is testing

Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 5,000
Large-scale testing (Phase 3)Study completedNCT01209780
What this trial is testing

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Who this might be right for
Seasonal Influenza
Novartis Vaccines 3,116
Next Page